🇺🇸 FDA
Patent

US 11427588

Compositions and methods for treating neurodegenerative diseases and cardiomyopathy

granted A61PA61P25/00A61P9/00

Quick answer

US patent 11427588 (Compositions and methods for treating neurodegenerative diseases and cardiomyopathy) held by The Regents of the University of California expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P25/00, A61P9/00